Chitosan-derived compositions
US12398215B2 · kind B2 · utility
0Cited by
13References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 23, 2023 |
| Grant date | Aug 26, 2025 |
| Priority date | — |
| Expiry date | Sep 11, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08B37/003
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Therapeutic compositions comprising chitosan-derived compositions are useful agents when administered in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.